Sofinnova Investments, Inc. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.47 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $262M, Gilead Sciences, Inc. with a value of $116M, Eli Lilly & CO with a value of $75.6M, Jazz Pharmaceuticals PLC with a value of $73.7M, and Vera Therapeutics, Inc. with a value of $65.8M.

Examining the 13F form we can see an increase of $114M in the current position value, from $1.36B to 1.47B.

Sofinnova Investments, Inc. is based out at Menlo Park, CA

Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.47 Billion
Healthcare: $1.37 Billion
ETFs: $101 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.47 Billion
  • Prior Value $1.36 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 11 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.